NYSE:PM - New York Stock Exchange, Inc. - US7181721090 - Common Stock
The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products meet public health standards and present lower risks than cigarettes and smokeless tobacco.
According to the agency, the pouches could even benefit cigarette smokers by helping them quit.
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized nicotine pouches.
Here are the biggest calls on Wall Street on Thursday.
While individual opportunities for strong share appreciation remain, a fresh focus area for 2025 might be dividend-paying stocks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Exxon Mobil, Philip Morris International and AT&T are part of the Zacks Investment Ideas article.
Exxon Mobil, AT&T and Philip Morris offer investors a defensive allocation in an uncertain market
The District of Columbia attorney general's office said it had found evidence that SMNA facilitated online sales of "tens of thousands" of flavored Zyn nicotine pouches to D.C. consumers between October 1, 2022, when the ban was enacted, and June 30, 2024. PMI, which acquired a 90% stake in Swedish Match for $16 billion in November 2022, must now monitor its distributor's compliance with D.C.'s ban quarterly and stop sales of flavored Zyn pouches through Zyn.com and related e-commerce platforms, the AG's office said on Friday.
A comparison between Altria (NYSE: MO) and Kraft Heinz (NASDAQ: KHC) will help explain the tightrope that turnaround investors have to walk. What does Altria do? Altria is one of the largest tobacco companies in the world.
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.